Physician profile
Joni Glavan Sago
NPI 1932187200
$661,425.54
in general payments reported to CMS, 2019-2025
14 companies · $112K in 2025
The $112K reported for 2025 was more than what 98% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $23K · 2021: $68K · 2022: $132K · 2023: $124K · 2024: $121K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $318K · Travel and Lodging: $27K · Food and Beverage: $7,660 · Consulting Fee: $5,045 · Honoraria: $260 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $317,575.00 |
| Travel and Lodging | $27,275.79 |
| Food and Beverage | $7,660.12 |
| Consulting Fee | $5,045.00 |
| Honoraria | $260.08 |
| Education | $127.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $577,368.80 | 2019-2025 | Rinvoq, Skyrizi |
| Galderma Laboratories, L.P. | $50,516.52 | 2024-2025 | Nemluvio |
| Pfizer INC. | $30,971.55 | 2020-2025 | |
| Janssen Biotech, INC. | $1,373.91 | 2020-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $354.55 | 2021-2025 | Dupixent |
| Janssen Scientific Affairs, LLC | $259.96 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $172.87 | 2024-2025 | Ebglyss, Olumiant |
| Ucb, INC. | $162.83 | 2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $123.24 | 2023-2025 | Sotyktu |
| Genzyme Corporation | $48.25 | 2021 | |
| Sun Pharmaceutical Industries INC. | $33.06 | 2022 | |
| Dermavant Sciences, INC. | $14.00 | 2023 | Vtama |
| Allergan, INC. | $13.49 | 2019 | |
| Incyte Corporation | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joni Sago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.